Grants / Department of Defense / Defense Health Agency Contracting Activity - DHACA

W81XWH-22-MRP-IA: DoD Melanoma, Idea Award

Closed Closed October 5, 2022 Opportunity W81XWH-22-MRP-IA ☆ Save

This grant is closed. A newer notice from the same program is open now: DoW Breast Cancer, Clinical Research Extension Award (HT942526BCRPCREA2). Status: Closes November 18, 2026 (11 days left). It is in our archive of Defense Health Agency Contracting Activity - DHACA notices from 2022.

• Total funding$10.4 million
• Expected awards13
• Cost sharingNot required
• Funding typeCooperative Agreement, Grant

Key dates

Who can apply

This opportunity was open to any type of organization.

• Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

More grants for nonprofits, colleges and universities, state and local governments, tribes, small businesses, businesses, individuals.

Is this a realistic fit?

• Most of the program's money (59% over five years) went to colleges and universities.
• No cost sharing or match is required.

What the grant funds

The FY22 MRP Idea Award supports innovative, untested, exploratory, high-risk/potentially high-reward concepts, theories, paradigms, and/or methods that are responsive to the FY22 MRP Challenge Statement and address at least one of the FY22 MRP Focus Areas in Section II.A.1. The advancement of knowledge in melanoma research, patient care, and/or treatment options in the Military Health System is critical to active-duty Service Members, Veterans, other military beneficiaries, and the American public. The purpose of the Idea Award is to generate novel research avenues for investigation; therefore, novelty and innovation should be key aspects of the proposed research. Research supported by the Idea Award must introduce a new paradigm, challenge existing paradigms, look at existing problems from new perspectives, or exhibit other highly creative qualities. The proposed project can be exploratory, hypothesis-driven or hypothesis-generating research but must be based on a strong scientific rationale and a well-developed study design and plan of analysis. The Idea Award is not intended to expand or extend previously published findings or continue an established line of research. Incremental advances, the next logical step, or merely switching the object or method of inquiry from one cancer to another cancer is not considered innovative.

Category: Science and Technology and other Research and Development.

Applying now

This notice no longer takes applications. Apply under the newer notice, HT942526BCRPCREA2, which is open now.

The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.